These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 14506828

  • 1. Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999.
    Wu X, Chen VW, Ruiz B, Andrews PA, Hsieh MC, Schmidt BA, Correa CN, Fontham ET.
    J La State Med Soc; 2003; 155(4):206-13. PubMed ID: 14506828
    [Abstract] [Full Text] [Related]

  • 2. The management of ductal carcinoma in situ of the breast: a screened population-based analysis.
    Rakovitch E, Pignol JP, Chartier C, Hanna W, Kahn H, Wong J, Mai V, Paszat L.
    Breast Cancer Res Treat; 2007 Mar; 101(3):335-47. PubMed ID: 16838110
    [Abstract] [Full Text] [Related]

  • 3. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM, Perry A, Strom EA, Babiera GV, Buchholz TA, Singletary E, Perkins GH, Ross MI, Schecter NR, Meric-Bernstam F, Ames FC, Hunt KK, Kuerer HM.
    Cancer; 2004 Feb 01; 100(3):490-8. PubMed ID: 14745864
    [Abstract] [Full Text] [Related]

  • 4. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV.
    Cancer; 2004 Aug 01; 101(3):508-17. PubMed ID: 15274063
    [Abstract] [Full Text] [Related]

  • 5. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival.
    Joslyn SA.
    Breast J; 2006 Aug 01; 12(1):20-7. PubMed ID: 16409583
    [Abstract] [Full Text] [Related]

  • 6. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH, Farley DR.
    Surg Oncol; 2003 Dec 01; 12(4):221-40. PubMed ID: 14998563
    [Abstract] [Full Text] [Related]

  • 7. Results of 23,810 cases of ductal carcinoma-in-situ.
    Sumner WE, Koniaris LG, Snell SE, Spector S, Powell J, Avisar E, Moffat F, Livingstone AS, Franceschi D.
    Ann Surg Oncol; 2007 May 01; 14(5):1638-43. PubMed ID: 17245612
    [Abstract] [Full Text] [Related]

  • 8. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI, Malone KE, Saltzman BS, Daling JR.
    Cancer; 2006 May 15; 106(10):2104-12. PubMed ID: 16604564
    [Abstract] [Full Text] [Related]

  • 9. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1514-21. PubMed ID: 16005576
    [Abstract] [Full Text] [Related]

  • 10. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
    Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B.
    Cancer; 2003 Oct 01; 98(7):1362-8. PubMed ID: 14508821
    [Abstract] [Full Text] [Related]

  • 11. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
    Worni M, Akushevich I, Greenup R, Sarma D, Ryser MD, Myers ER, Hwang ES.
    J Natl Cancer Inst; 2015 Dec 01; 107(12):djv263. PubMed ID: 26424776
    [Abstract] [Full Text] [Related]

  • 12. [Trends in incidence and treatment of ductal carcinoma in situ of the breast in southeast Netherlands].
    Voogd AC, Crommelin MA, Repelaer van Driel OJ, Nolthenius-Puylaert MC, van der Heijden LH, Coebergh JW.
    Ned Tijdschr Geneeskd; 2000 Apr 01; 144(14):659-63. PubMed ID: 10774294
    [Abstract] [Full Text] [Related]

  • 13. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    EORTC Breast Cancer Cooperative GroupDepartment of Radiation Oncology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands. n.bijker@nki.nl, EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ.
    J Clin Oncol; 2006 Jul 20; 24(21):3381-7. PubMed ID: 16801628
    [Abstract] [Full Text] [Related]

  • 14. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M, Julian TB, Werts DE, McWilliams W, Kim Y, Miften M, Parda D.
    Am J Clin Oncol; 2009 Jun 20; 32(3):314-8. PubMed ID: 19451803
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effectiveness of radiation therapy in older women with ductal carcinoma in situ.
    Smith BD, Haffty BG, Buchholz TA, Smith GL, Galusha DH, Bekelman JE, Gross CP.
    J Natl Cancer Inst; 2006 Sep 20; 98(18):1302-10. PubMed ID: 16985249
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ.
    Yen TW, Hunt KK, Mirza NQ, Thomas ES, Singletary SE, Babiera GV, Meric-Bernstam F, Buchholz TA, Feig BW, Ross MI, Ames FC, Theriault RL, Kuerer HM.
    Cancer; 2004 Mar 01; 100(5):942-9. PubMed ID: 14983489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.